Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects

被引:59
作者
Larkin, T. A. [1 ,2 ]
Astheimer, L. B. [1 ,2 ]
Price, W. E. [2 ,3 ]
机构
[1] Univ Wollongong, Dept Biomed Sci, Wollongong, NSW 2522, Australia
[2] Univ Wollongong, ARC, Smart Foods Key Ctr, Wollongong, NSW 2522, Australia
[3] Univ Wollongong, Dept Chem, Wollongong, NSW 2522, Australia
基金
澳大利亚研究理事会;
关键词
isoflavones; probiotic; prebiotic; lipids; bioavailability; equol; FERMENTED MILK PRODUCT; IMPROVE PLASMA-LIPIDS; GUT MICROFLORA; LACTOBACILLUS-ACIDOPHILUS; CARDIOVASCULAR-DISEASE; INTESTINAL MICROFLORA; RESISTANT STARCH; BLOOD-LIPIDS; RISK-FACTORS; ISOFLAVONES;
D O I
10.1038/sj.ejcn.1602910
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: We hypothesized that a dietary combination of soy with either a probiotic (yoghurt) or a prebiotic (resistant starch) would result in enhanced lipid-lowering effects compared with a control soy diet, possibly via improvements in isoflavone bioavailability. Subjects: Mildly hypercholesterolaemic subjects (men and post-menopausal women) older than 45 years were recruited via the local media. Thirty-six subjects commenced the study; five withdrew. Results: Soy + probiotic significantly decreased total cholesterol (4.7 +/- 2.0%; P=0.038) and soy + prebiotic significantly decreased total and low-density lipoprotein cholesterol (5.5 +/- 1.6%; P=0.003 and 7.3 +/- 2.2%; P=0.005, respectively). The bioavailabilities of daidzein, genistein or equol were not affected by probiotic or prebiotic consumption or associated with lipid changes. Conclusion: Dietary combination of soy with either a probiotic or a prebiotic resulted in significant lipid lowering, not related to isoflavone bioavailability.
引用
收藏
页码:238 / 245
页数:8
相关论文
共 46 条
  • [21] Colonic bacterial activity and serum lipid risk factors for cardiovascular disease
    Jenkins, DJA
    Vuksan, V
    Rao, AV
    Vidgen, E
    Kendall, CWC
    Tariq, N
    Würsch, P
    Koellreutter, B
    Shiwnarain, N
    Jeffcoat, R
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (02): : 264 - 268
  • [22] LARKIN T, 2005, THESIS U WOLLONGONG
  • [23] Soy protein, isoflavones and cardiovascular disease risk
    Lichtenstein, AH
    [J]. JOURNAL OF NUTRITION, 1998, 128 (10) : 1589 - 1592
  • [24] Merz-Demlow BE, 2000, AM J CLIN NUTR, V71, P1462
  • [25] Modulation of fecal markers relevant to colon cancer risk: a high-starch Chinese diet did not generate expected beneficial changes relative to a western-type diet
    Muir, JG
    Walker, KZ
    Kaimakamis, MA
    Cameron, MA
    Govers, MJAP
    Lu, ZX
    Young, GP
    O'Dea, K
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (02) : 372 - 379
  • [26] Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
    Nestel, PJ
    Yamashita, T
    Sasahara, T
    Pomeroy, S
    Dart, A
    Komesaroff, P
    Owen, A
    Abbey, M
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (12) : 3392 - 3398
  • [27] Screening of intestinal microflora for effective probiotic bacteria
    O'Sullivan, DJ
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (04) : 1751 - 1760
  • [28] Parodi PW, 1999, AUST J DAIRY TECHNOL, V54, P103
  • [29] Effects of consumption of probiotics and prebiotics on serum lipid levels in humans
    Pereira, DIA
    Gibson, GR
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 37 (04) : 259 - +
  • [30] Soy protein and cardiovascular disease: The impact of bioactive components in soy
    Potter, SM
    [J]. NUTRITION REVIEWS, 1998, 56 (08) : 231 - 235